Regulatory Clarification from Themis Medicare Limited
Summary of Company's Response
The company has issued a formal clarification to the stock exchanges regarding unusual trading volume activity in its securities.
Date and Nature of Exchange Query
- Date of Communication: 07th September, 2026
- Recipients: Corporate Relationship Department of BSE Limited and Listing Department of National Stock Exchange of India Limited.
- Nature of Query: The communication is a response to an email from the exchanges dated 07th September, 2026, seeking clarification on the increase in volume movement of the company's securities.
Company’s Clarification on Trading Volume
- The company stated that there is no pending or delayed disclosure of any material information.
- This confirmation is specifically made in relation to the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Reference to Regulatory Compliance
- The company emphasized its adherence to SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
- It asserted that it has been regularly disseminating all relevant information and details in a timely manner whenever disclosure is required.
Details of Financial Results Clarification
The document does not contain any discussion or clarification related to financial results.
Signatory and Sentiment
- The letter was signed by Sachin D. Patel, Managing Director & CEO (DIN: 00033353).
- Topic Tags: Regulatory Response, Stock Trading, Volume Increase, Compliance, SEBI LODR